PedAM
Pediatric Disease Annotations & Medicines
| Disease | psoriasis |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 31 |
| PubMedID- 22113483 | psoriasis is associated with metabolic syndrome and the association increases with increasing disease severity. |
| PubMedID- 21786331 | Conclusions: these results suggest that according to the criteria of the idf, the significant decrease observed in serum paraoxonase activity was independent of the metabolic syndrome in patients with mild-to-moderate plaque-type psoriasis, whereas the significant decrease in serum arylesterase activity was associated with the metabolic syndrome. |
| PubMedID- 24974491 | Results: there was higher prevalence of hypertension, hypertriglyceridaemia, diabetes mellitus and metabolic syndrome in patients with psoriasis than in controls. |
| PubMedID- 24350027 | metabolic syndrome is associated with psoriasis, acanthosis nigricans, etc. |
| PubMedID- 21482893 | Lack of appropriate screening for the metabolic syndrome in patients with psoriasis risks underrecognition and undertreatment of important comorbidities: comment on "prevalence of the metabolic syndrome in psoriasis". |
| PubMedID- 22363149 | Objective: the purpose of this study was to evaluate risk factors for metabolic syndrome in psoriasis patients and to compare the prevalence of metabolic syndrome in psoriasis and control groups. |
| PubMedID- 24551670 | We did not find any association of psoriasis with metabolic syndrome in our study. |
| PubMedID- 26481956 | Other dermatoses such as psoriasis are associated with risk factors (metabolic syndrome) for sexual disorders and may therefore indirectly induce erectile dysfunction. |
| PubMedID- 23983796 | psoriasis is associated with metabolic syndrome and several inflammatory diseases including rheumatoid arthritis and crohn's disease [3]. |
| PubMedID- 26148122 | metabolic syndrome in psoriasis patients. |
| PubMedID- 23360868 | Based on random-effects modeling of cross-sectional and case-controlled studies, the pooled odds ratio (or) for metabolic syndrome among patients with psoriasis was 2.26 (95% confidence interval [ci] 1.70-3.01) compared with the general population. |
| PubMedID- 26005254 | The incidence of metabolic syndrome in patients with psoriasis was 38,57%. |
| PubMedID- 24371391 | According to a previous report, the severity of psoriasis is associated with metabolic syndrome in a dose-response manner. |
| PubMedID- 23837273 | Prevalence of metabolic syndrome in patients with psoriasis at mostar clinical hospital. |
| PubMedID- 24592364 | Apart from the predictable association of psoriasis with obesity and metabolic syndrome, a detailed history was taken from each patient regarding involved or deteriorating factors (bacterial infections, human immunodeficiency virus infection, pregnancy, hypocalcemia and causative drug consumption including terbinafine, non-steroidal anti-inflammatory drugs, anti-malarias, angiotensin-converting enzyme inhibitors, lithium, interferon [ifn] and beta blockers). |
| PubMedID- 22490453 | Although severe psoriasis can be associated with eosinophilia and metabolic syndrome, acute pulmonary embolism is very rare in these patients. |
| PubMedID- 24267013 | Background and objectives: previous studies have shown a higher prevalence of metabolic syndrome in patients with psoriasis compared to controls. |
| PubMedID- 24459670 | psoriasis is associated with metabolic syndrome and the association increases with increasing disease severity [7]. |
| PubMedID- 22654590 | Our aim was to investigate the prevalence of metabolic syndrome in patients with psoriasis vulgaris. |
| PubMedID- 23158933 | psoriasis is linked with metabolic syndrome, insulin resistance, and non-alcoholic fatty liver disease, which are features often associated with pcos. |
| PubMedID- 23919006 | A large study in the american population including 6549 participants revealed a high incidence of metabolic syndrome in patients with psoriasis, with abdominal obesity, followed by hypertriglyceridemia and low levels of high-density lipoprotein cholesterol, but not diabetes. |
| PubMedID- 21054959 | Objective: to explore the prevalence of metabolic syndrome in psoriasis inpatients in peking union medical hospital. |
| PubMedID- 21079309 | Conclusion: there is a significantly higher prevalence of metabolic syndrome in psoriasis patients as compared to general population and so is the risk of having atherosclerotic adversity. |
| PubMedID- 23479005 | Other inflammatory markers and related factors should be kept in mind in metabolic syndrome with psoriasis patients. |
| PubMedID- 25230056 | Multiple epidemiologic studies have revealed a high prevalence of metabolic syndrome in patients with psoriasis compared with other skin diseases. |
| PubMedID- 24495197 | A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis. |
| PubMedID- 21173301 | The most common feature of the metabolic syndrome among patients with psoriasis was abdominal obesity, followed by hypertriglyceridemia and low levels of high-density lipoprotein cholesterol. |
| PubMedID- 25291969 | Furthermore, psoriasis with metabolic syndrome showed significantly higher serum crp levels than those without the metabolic syndrome. |
| PubMedID- 21737375 | Role of serum uric acid in conditioning the association of psoriasis with metabolic syndrome. |
| PubMedID- 24772493 | A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis. |
| PubMedID- 19887761 | Background: psoriasis is associated with obesity and metabolic syndrome. |
Page: 1